Pelagic’s team brings together operators and scientists with experience in synthetic biology, precision fermentation, pharmaceutical and lipid chemistry, metabolomics, nutrition, regulatory development, manufacturing, finance and commercialisation. Together, the team covers the full route from biological discovery and product design to scale-up and market.
Pelagic’s scientific advisory board contributes specialist expertise in ether-lipid biology, lipidomics, clinical translation and manufacturing-process development.
-
Prof. Peter Meikle
Head of Metabolomics Lab at Baker Heart & Diabetes Institute
-
Dr. Sudip Paul
Research Officer
at Baker Heart & Diabetes Institute -
Dr. Roberto Angelini
Expert in lipidomics & ether lipids in neurodegenerative disease
-
Dr. Paula Hicks
Senior scientist, clinical application and IP strategy
